பல மருந்து எதிர்ப்பு ப்ரோடீந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பல மருந்து எதிர்ப்பு ப்ரோடீந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பல மருந்து எதிர்ப்பு ப்ரோடீந் Today - Breaking & Trending Today

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19


Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19
A rapid spread of the virus that caused symptoms similar to severe pneumonia was first reported in Wuhan, China, in December 2019. Scientists found that this novel virus belonged to the family Coronaviridae and was later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Worldwide, researchers are developing various vaccines, medicines, facemasks, and many other means to contain the SARS-CoV-2 infection.
Among various antiviral drugs, remdesivir has been approved for the treatment of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 infection. Remdesivir is a nucleoside analog that inhibits the SARS-CoV-2 RNA-dependent RNA-polymerase (RdRp). It is a virus polymerase inhibitor that involves the termination of both the viral transcript and newly synthesized viral genomes. However, there are some limitations that have escalated the need to develop other potenti ....

Priyom Bose , Ekaterina Bondaretc Shutterstock , Ekaterina Bondaretc , Multi Drug Resistance Protein , Antiviral Drug , Coronavirus Disease Covid 19 , Drug Repurposing , Sars Cov 2 , Corona Virus , In Vitro , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , பிரீயோம் போஸ் , பல மருந்து எதிர்ப்பு ப்ரோடீந் , மருந்து மறுபயன்பாடு , கொரோனா வைரஸ் , இல் விட்ரோ , கடுமையானது எடுப்போசை சுவாச , கடுமையானது எடுப்போசை சுவாச நோய்க்குறி ,